Abdulmajid Al Arfaj

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

Y. Arabi, A. Bouchama, Faisal Alharbi, 2021, Infectious Diseases and Therapy.